Delivery Order SPE2DB20D3505-SPE2DB22FT8W4
Award Date 6/6/22
Potential Completion Date 6/7/22
Potential Value $4.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,000 units of the drug Lisinopril-HCTZ 20-25 mg. The single-award, firm-fixed price delivery order, valued at $2,066.47, has a completion date of July 28, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,377,307 units of the prescription drug Lisinopril 40 mg tablets. The contract, valued at $2,632.97, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major Defense agency, on a full and open competition basis without any set-aside designation. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a federal contract award valued at $7,856.00 issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of 1,000 units of the medication Lisinopril-HCTZ 10-12.5 mg tablets. This award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific delivery order, valued at...
- This federal contract award, valued at $1,243.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,560,701,371 units of Lisinopril 20 mg tablets, a cardiovascular medication, with an ultimate completion date of April 25, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,654.66, is a delivery order for 4,563,436,091 tablets of the generic drug Lisinopril 10 mg. The award has an ultimate completion date of January 25, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,000 units of 40 mg Lisinopril tablets. The contract has a ceiling value of $4,312.22 and runs through February 27, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $2,487.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of the drug Lisinopril, a cardiovascular medication, with a completion date of November 19, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
- This federal contract award, with a value of $12,344.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,605,288 Lisinopril 10 mg tablets, a common blood pressure medication. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of May 15, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the...
- This federal contract award, valued at $1,266.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order (SPE2DB22D1041|SPE2DB25FUAP8) for the supply of 4,568,175,234 tablets of the drug Lisinopril 10 mg. The contract has an ultimate completion date of May 8, 2025 and is a firm fixed-price arrangement. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp...